Similar articles for PMID: 31892575

Year	Number of Results
1948	1
2011	1
2015	6
2016	23
2017	34
2018	35
2019	26
2020	23
2021	18
2022	4

1

Prognostic Significance of Tumor Immunity in Surgically Resected Pulmonary Pleomorphic Carcinoma.

Kaira K, Shimizu K, Endoh H, Imaizumi K, Kamiyoshihara M, Sugano M, Kawashima O, Tanaka S, Fujita A, Imai H, Kogure Y, Oyama T, Asao T, Shirabe K. Kaira K, et al. Anticancer Res. 2020 Jan;40(1):261-269. doi: 10.21873/anticanres.13948. Anticancer Res. 2020. PMID: 31892575

2

Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma.

Hu C, Tian S, Lin L, Zhang J, Ding H. Hu C, et al. Oral Oncol. 2020 Mar;102:104560. doi: 10.1016/j.oraloncology.2019.104560. Epub 2020 Jan 7. Oral Oncol. 2020. PMID: 31923855

3

Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung.

Imanishi N, Hirai A, Yoneda K, Shimajiri S, Kuwata T, Tashima Y, Takeuchi M, Iwai Y, Ichiki Y, Tanaka F. Imanishi N, et al. J Surg Oncol. 2018 Jun;117(7):1563-1569. doi: 10.1002/jso.25041. Epub 2018 Mar 30. J Surg Oncol. 2018. PMID: 29601633

4

Prognostic value of PD-L1 expression in combination with CD8⁺ TILs density in patients with surgically resected non-small cell lung cancer.

Yang H, Shi J, Lin D, Li X, Zhao C, Wang Q, Zhang L, Jiang T, Zhao S, Liu X, Jia Y, Zhang Y, Cai W, Zhou C. Yang H, et al. Cancer Med. 2018 Jan;7(1):32-45. doi: 10.1002/cam4.1243. Epub 2017 Nov 23. Cancer Med. 2018. PMID: 29168339 Free PMC article.

5

Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.

Rashed HE, Abdelrahman AE, Abdelgawad M, Balata S, Shabrawy ME. Rashed HE, et al. Turk Patoloji Derg. 2017;1(1):211-222. doi: 10.5146/tjpath.2017.01398. Turk Patoloji Derg. 2017. PMID: 28832075 Free article. English.

6

Prognostic Significance of Programmed Death Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Axial Osteosarcoma.

Liu P, Xiao Q, Zhou B, Dai Z, Kang Y. Liu P, et al. World Neurosurg. 2019 Sep;129:e240-e254. doi: 10.1016/j.wneu.2019.05.121. Epub 2019 May 22. World Neurosurg. 2019. PMID: 31128313

7

The landscape of immune microenvironment in lung adenocarcinoma and squamous cell carcinoma based on PD-L1 expression and tumor-infiltrating lymphocytes.

Chen L, Cao MF, Zhang X, Dang WQ, Xiao JF, Liu Q, Tan YH, Tan YY, Xu YY, Xu SL, Yao XH, Cui YH, Zhang X, Bian XW. Chen L, et al. Cancer Med. 2019 Dec;8(17):7207-7218. doi: 10.1002/cam4.2580. Epub 2019 Oct 11. Cancer Med. 2019. PMID: 31605439 Free PMC article.

8

Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.

Wang H, Li Z, Dong B, Sun W, Yang X, Liu R, Zhou L, Huang X, Jia L, Lin D. Wang H, et al. Diagn Pathol. 2018 May 22;13(1):30. doi: 10.1186/s13000-018-0712-1. Diagn Pathol. 2018. PMID: 29789013 Free PMC article.

9

Prognostic value of tumor PD-L1 expression combined with CD8⁺ tumor infiltrating lymphocytes in high grade serous ovarian cancer.

Wang Q, Lou W, Di W, Wu X. Wang Q, et al. Int Immunopharmacol. 2017 Nov;52:7-14. doi: 10.1016/j.intimp.2017.08.017. Epub 2017 Aug 31. Int Immunopharmacol. 2017. PMID: 28846888

10

Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8⁺ Tumor-Infiltrating Lymphocytes Identified Patients With Poor Prognosis in Rectal Cancer: A Matched Comparison Analysis.

Lim YJ, Koh J, Kim S, Jeon SR, Chie EK, Kim K, Kang GH, Han SW, Kim TY, Jeong SY, Park KJ, Wu HG. Lim YJ, et al. Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1216-1224. doi: 10.1016/j.ijrobp.2017.07.004. Int J Radiat Oncol Biol Phys. 2017. PMID: 29165286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed